Data / Form D filings / Amend Surgical, Inc.
Amend Surgical, Inc.: Form D filings
Amend Surgical, Inc., a biotechnology company in Gainesville, FL, filed 5 Form D notices with the SEC between 2015 and 2024. The latest, on June 25, 2024, reports $1 million sold of a $3.5 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5134 SW 106th Way, Gainesville, FL, 32608
- Phone
- (844) 281-3169
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1656957
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2024 | New notice | $3,500,000 | $1,049,473 | $2,450,527 | 5 | Jun 11, 2024 | sec.gov |
| May 5, 2022 | New notice | $500,000 | $371,287 | $128,713 | 9 | Apr 22, 2022 | sec.gov |
| Apr 5, 2017 | New notice | $200,000 | $200,000 | 3 | Feb 1, 2017 | sec.gov | |
| Apr 15, 2016 | New notice | $1,100,000 | $650,000 | $450,000 | 4 | Sep 30, 2015 | sec.gov |
| Dec 21, 2015 | New notice | Indefinite | $0 | 1 | Dec 7, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ronald R. Cobb | Director | |
| James F. Kirk | Director | |
| Wade F. Pilling | Director | |
| Michael R. Orrico | Director | |
| Robert Lane | Executive Officer, Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Jun 24, 2024 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Amend Surgical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.